Skip to main content
Arcadia Biosciences, Inc.AB
SEC Form D filing

Arcadia Biosciences, Inc.

Biotech · Series A · Regulation D 506(b) · TX · Filed June 26, 2026

Offering amount
$11.4M
Exemption
Reg D 506(b)
Issuer state
TX
Filing date
June 26, 2026
Signature date
June 18, 2026
CIK
0001469443

Summary

Auto-generated

Arcadia Biosciences, Inc. is a biotech company raising $11.4M under 506(b), consistent with series-a stage. The name directly identifies a biotech operating entity.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.